GlassScriptPhysician profile
Allyson R Grimaldi
NPI 1912422106
$1,348.00
in general payments reported to CMS, 2019-2025
18 companies · $637 in 2025
The $637 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $96.58 · 2022: $136 · 2024: $478 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,115.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $423.81 | 2021-2025 | |
| Novo Nordisk INC | $142.82 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $109.13 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $95.42 | 2021-2025 | Mounjaro, Zepbound |
| Astellas Pharma US INC | $75.70 | 2025 | Veozah |
| Sumitomo Pharma America, INC. | $73.99 | 2024-2025 | Gemtesa |
| Otsuka America Pharmaceutical, INC. | $73.85 | 2022-2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.34 | 2022-2025 | Xifaxan |
| Eisai INC. | $55.02 | 2024-2025 | |
| Amgen INC. | $47.91 | 2024-2025 | Evenity, Prolia, Repatha |
| Abbott Laboratories | $41.42 | 2024-2025 | Freestyle Libre 3 |
| Lundbeck LLC | $30.78 | 2025 | Rexulti |
| Exact Sciences Corporation | $28.34 | 2025 | Cologuard Collection Kit |
| Alexion Pharmaceuticals, INC. | $22.34 | 2025 | Strensiq |
| Kowa Pharmaceuticals America, INC. | $20.68 | 2024 | Zoryve |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $19.41 | 2022 | |
| Phadia US INC. | $18.39 | 2025 | Immunocap |
| E.R. Squibb & Sons, L.L.C. | $13.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allyson Grimaldi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.